← Eichor
Study identifier: NCT06123156 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer

Condition: Rectal Cancer  ·  Sponsor: University Hospital, Rouen

PhasePhase 3
Planned participants188
Who can joinMale, 18 Years to 70 Years
Healthy volunteersNo

About this study

This study aims to evaluate the efficacy of erectile rehabilitation with Sildenafil, in men treated with neoadjuvant proctectomy and radiotherapy for rectal cancer, in preventing long-term erectile dysfunction at 12 months post-operatively.

This description comes directly from the study's public registry record.

Talk to the study team

Valérie Bridoux  ·  0232881347  ·  valerie.bridoux@chu-rouen.fr

Julie Rondeaux, PhD  ·  0232885427  ·  julie.rondeaux@chu-rouen.fr

Always discuss trial participation with your own doctor first.

Locations (14)

Chu AmiensAmiens, FranceRecruiting
Hopital BeauvaisBeauvais, FranceRecruiting
Chu BesanconBesançon, FranceRecruiting
Aphp BicetreBicêtre, FranceRecruiting
Chu BordeauxBordeaux, FranceRecruiting
Institut Bordeaux ColorectalBordeaux, FranceRecruiting
Chu Clermont-FerrandClermont-Ferrand, FranceRecruiting
Chu LilleLille, FranceRecruiting
Institut Paoli-CalmettesMarseille, FranceRecruiting
Institut Du Cancer MontpellierMontpellier, FranceRecruiting
Aphp St AntoineParis, FranceRecruiting
Aphp HegpParis, FranceRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06123156